Loading…
Thermo Fisher Scientific Inc. is projected to rise to $604.62 by 2027, a +15% move from its current price of $524.71. TMO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $516.23 | $524.76 | $533.42 | +0.01% |
| Jul 14 | $512.79 | $524.80 | $537.10 | +0.02% |
| Jul 15 | $510.17 | $524.85 | $539.95 | +0.03% |
| Jul 16 | $507.98 | $524.90 | $542.37 | +0.04% |
| Jul 17 | $506.07 | $524.94 | $544.52 | +0.04% |
| Jul 18 | $504.35 | $524.99 | $546.48 | +0.05% |
| Jul 19 | $502.77 | $525.04 | $548.28 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $502.77 | $525.04 | $548.28 | +0.06% |
| Week 2 | $494.14 | $525.36 | $558.56 | +0.12% |
| Week 3 | $487.68 | $525.69 | $566.66 | +0.19% |
| Week 4 | $482.35 | $526.02 | $573.63 | +0.25% |
| Week 5 | $477.74 | $526.34 | $579.89 | +0.31% |
| Week 6 | $473.64 | $526.67 | $585.64 | +0.37% |
| Week 7 | $469.92 | $527.00 | $591.01 | +0.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.
Its Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings.
Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Thermo Fisher Scientific Inc. is a healthcare stock with a market-capitalization footprint of $190.65B and a current price of $513.03. It is ranked 70 by market capitalization among listed assets in its category.
The current price sits within a forecast pathway that projects upside over the coming years, with the 2026 average at $513.03 and the forecast extending to higher levels through 2050, including a 2030 average of $810.30 and a 2050 average of $3,538.11. These projections imply meaningful appreciation across the multi-year horizon, with max forecast values reaching $5,786.30 by 2050. The forecast shows a bullish tilt beginning in 2029 and continuing through 2050, with progressively higher average prices and ROIs.
A major floor 16.5% below — a decisive break under it would weaken the trend.
The nearest floor, 12.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.4% away) — a breakout level to watch.
A major ceiling 8.8% above — clearing it would confirm fresh momentum.
Key TMO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TMO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $519.22 | Buy | $520.21 | Buy |
| MA 10 | $515.37 | Buy | $513.15 | Buy |
| MA 20 | $495.13 | Buy | $501.82 | Buy |
| MA 50 | $477.55 | Buy | $490.90 | Buy |
| MA 100 | $487.65 | Buy | $496.73 | Buy |
| MA 200 | $527.51 | Sell | $505.69 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.00 | Neutral |
| Stoch RSI (14) | 91.68 | Sell |
| CCI (20) | 99.91 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 2.79 | Buy |
| ROC (12) | 12.29 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.32 | Buy |
| Awesome (5,34) | 32.90 | Buy |
| Ultimate (7,14,28) | 72.98 | Sell |
| Momentum (10) | 21.30 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 521.89 | Buy |
| ADX (14) | 19.88 | Neutral |
| ATR (14) | 7.76 | Info |
The 30-day technical picture is bullish with RSI14 at 70. The 50-day simple moving average (SMA50) is $474.37 and the 200-day simple moving average (SMA200) is $525.86. Near-term support sits at $438.34 and resistance at $513.03, while the 30-day price range runs from $454.71 to $578.82.
The price action suggests upside potential within a defined band, with elevated activity typical of a stock trading near resistance in a bullish setup.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $438.34 | $524.71 | $656.43 | 0% | Neutral | |
| $495.17 | $604.62 | $771.88 | +15% | Neutral | |
| $499.75 | $621.68 | $815.11 | +18% | Neutral | |
| $550.69 | $695.61 | $931.45 | +33% | Bullish | |
| $657.01 | $841.12 | $1,146.58 | +60% | Bullish | |
| $727.09 | $942.20 | $1,304.67 | +80% | Bullish | |
| $798.90 | $1,046.96 | $1,470.35 | +100% | Bullish | |
| $854.82 | $1,132.03 | $1,610.40 | +116% | Bullish | |
| $879.23 | $1,175.94 | $1,692.86 | +124% | Bullish | |
| $920.40 | $1,242.66 | $1,808.82 | +137% | Bullish | |
| $1,362.25 | $1,918.29 | $2,926.14 | +266% | Bullish | |
| $2,502.21 | $3,778.97 | $6,179.00 | +620% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $438.34 | $524.71 | $619.08 | +0.00% |
| August 2026 | $442.83 | $518.43 | $620.11 | -1.20% |
| September 2026 | $449.69 | $528.97 | $637.64 | +2.03% |
| October 2026 | $458.72 | $541.80 | $657.39 | +2.42% |
| November 2026 | $453.76 | $537.80 | $656.14 | -0.74% |
| December 2026 | $450.22 | $535.32 | $656.43 | -0.46% |
Click any year to see its month-by-month TMO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The TMO price prediction for 2026 points to an average of $524.71 (low $438.34, high $656.43) — a potential gain of 0% on today's $524.71. A consolidation phase looks the most probable path here.
In 2027, TMO is projected to trade between $495.17 and $771.88, averaging $604.62 — a potential gain of +15% from today's $524.71. That is up +15% on the projected 2026 average. Price action looks broadly range-bound.
Thermo Fisher Scientific Inc.'s 2028 outlook centres on $621.68, within a $499.75 to $815.11 range. That is up +3% on the projected 2027 average. That marks a +18% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, TMO could reach as high as $931.45, with a base case around $695.61 and support toward $550.69 — roughly +33% from $524.71. Momentum favours further upside here.
Expect TMO to range from $657.01 to $1,146.58 through 2030. The $841.12 average target implies a +60% move from current prices. That is up +21% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The TMO price prediction for 2031 points to an average of $942.20 (low $727.09, high $1,304.67) — a potential gain of +80% on today's $524.71. Momentum favours further upside here.
In 2032, TMO is projected to trade between $798.90 and $1,470.35, averaging $1,046.96 — a potential gain of +100% from today's $524.71. That is up +11% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Thermo Fisher Scientific Inc.'s 2033 outlook centres on $1,132.03, within a $854.82 to $1,610.40 range. That is up +8% on the projected 2032 average. That marks a +116% change versus current levels. Momentum favours further upside here.
By 2034, TMO could reach as high as $1,692.86, with a base case around $1,175.94 and support toward $879.23 — roughly +124% from $524.71. Buyers look set to stay in control over this stretch.
Expect TMO to range from $920.40 to $1,808.82 through 2035. The $1,242.66 average target implies a +137% move from current prices. That is up +6% on the projected 2034 average. Momentum favours further upside here.
The TMO price prediction for 2040 points to an average of $1,918.29 (low $1,362.25, high $2,926.14) — a potential gain of +266% on today's $524.71. Buyers look set to stay in control over this stretch.
In 2050, TMO is projected to trade between $2,502.21 and $6,179.00, averaging $3,778.97 — a potential gain of +620% from today's $524.71. That is up +97% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in TMO today (≈ 1.905815 TMO) could be worth
$7,202.01
+$6,202.01 (+620%) by 2050 · US Dollar
Based on the average projected TMO price of $3,778.97 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TMOwould be worth at today's price.
$1,000 invested in TMO on Jul 10, 2025 (≈ 2.32164 TMO) would be worth
$1,218.19
+$218.19 (+21.8%) today · 1.22× · US Dollar
Based on a TMO entry price of $430.73 vs. today's $524.71.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $523.44 | $1,002.43 | +0.2% |
| 1 month ago | $482.04 | $1,088.52 | +8.9% |
| 3 months ago | $496.11 | $1,057.65 | +5.8% |
| 6 months ago | $615.45 | $852.56 | -14.7% |
| 1 year ago | $430.73 | $1,218.19 | +21.8% |
| All time (5.0y) ago | $514.3 | $1,020.24 | +2.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TMO forecast.
Our base-case forecast reaches $1,000.00 around 2032.
Implied market cap at $1,000.00: $371.62B
The multi-year outlook shows a progressive rise in expected prices, with 2029 average $675.76 and ROI 31.7%, followed by continued gains through 2035. By 2030 the average is projected to $810.30 with ROI 57.9% and continued bullish sentiment. The path extends to 2040 with an average of $1,785.69 and ROI 248.1%, and to 2050 with an average of $3,538.11 and ROI 589.6%.
Intermediate years also reflect rising averages: 2032 average $1,004.80 (ROI 95.9%), 2033 average $1,083.17 (ROI 111.1%), 2034 average $1,102.86 (ROI 115%), and 2035 average $1,181.26 (ROI 130.3%). These figures are estimates, not guarantees, and reflect the modeled forecasts for a long-term investment horizon.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $810.30, a min of $632.67 and a max of $1,105.17, with a ROI of 57.9% and bullish sentiment.
Forecasts show a path of rising averages from 2027 onward, with 2027 average $588.06, 2028 average $598.21, 2029 average $675.76, 2030 average $810.30, 2040 average $1,785.69, and 2050 average $3,538.11, with increasing ROIs and bullish sentiment from 2029 onward.
Yes. The forecast indicates a 2032 minimum of $766.46 and an average of $1,004.80 with a maximum of $1,411.77, and 2033 average $1,083.17, suggesting values above $1,000 in that period.
The 30-day range is $454.71 to $578.82.
Current price is $513.03 and market cap is $190.65B; the asset is ranked 70 by market capitalization.
Thermo Fisher Scientific Inc. Community Discussion
0Share your Thermo Fisher Scientific Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.